Abstract | OBJECTIVE: METHODS AND RESULTS:
ApoE-/- mice were alpha1-deficient or received early or delayed anti-alpha1 antibody treatment. Deficiency in alpha1 integrin reduced the area of atherosclerotic plaques and altered plaque composition by reducing inflammation and increasing extracellular matrix. In advanced plaques, alpha1-deficient mice had a reduced macrophage and CD3+ cell content, collagen and smooth muscle cell content increased, lipid core sizes decreased, and cartilaginous metaplasia occurred. Anti-alpha1 antibody treatment reduced the macrophage content in initial plaques after early and delayed treatment, decreased the CD3+ cell content in advanced plaques after delayed treatment, and increased the collagen content in initial and advanced plaques after delayed treatment. Migration assays performed on alpha1-deficient macrophages on collagen I and IV substrata revealed that alpha1-deficient cells can migrate on collagen I, but not IV. Anti-alpha1 antibody treatment of ApoE-/- macrophages also inhibited migration of cells on collagen IV. CONCLUSIONS:
|
Authors | Kitty Schapira, Esther Lutgens, Antonin de Fougerolles, Andrew Sprague, Anouk Roemen, Humphrey Gardner, Victor Koteliansky, Mat Daemen, Sylvia Heeneman |
Journal | Arteriosclerosis, thrombosis, and vascular biology
(Arterioscler Thromb Vasc Biol)
Vol. 25
Issue 9
Pg. 1917-24
(Sep 2005)
ISSN: 1524-4636 [Electronic] United States |
PMID | 15976328
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies
- Apolipoproteins E
- Collagen Type IV
- Integrin alpha1beta1
|
Topics |
- Animals
- Antibodies
(pharmacology)
- Apolipoproteins E
(genetics)
- Atherosclerosis
(genetics, immunology, physiopathology)
- Cell Adhesion
(immunology)
- Cell Movement
(immunology)
- Collagen Type IV
(genetics, metabolism)
- Female
- Gene Deletion
- Gene Expression
- Integrin alpha1beta1
(genetics, immunology, metabolism)
- Leukocytes
(cytology, immunology)
- Male
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Mice, Mutant Strains
- Phenotype
|